Apex Medical Corp (雃博) said yesterday that the US International Trade Commission ruled last week that its Wizard 220 facial mask and XT continuous positive airway pressure (CPAP) machines do not infringe on the patents of US-based ResMed Inc.
That means the two devices to treat sleep apnea can be sold in the US, the local medical supplies producer said.
However, the commission also ruled that the Taiwanese firm’s water tank design for its iCH series CPAP machine infringed on ResMed’s patents.
Australia-based ResMed manufactures products for sleep-apnea breathing therapy.
The rulings issued on Friday last week were the final judgement made by the commission and the two companies cannot appeal, Apex Medical deputy spokesperson Joan Wang (王家蘭) said by telephone.
Wang said the company would immediately launch its XT CPAP machines and Wizard 220 facial mask in the US, and launch its iCH series CPAP machine there in October, after it makes modifications to the design of the water tank of the machine.
Meanwhile, the firm is still in the process of attempting to invalidate ResMed’s five patents in the US Patent and Trademark Office, Wang said. The company said the results of its lawsuit are expected in the beginning of next year.
From January through last month, the company posted revenue of NT$1.17 billion (US$39.02 million), up 17.87 percent from NT$992.69 million a year ago, which Wang attributed to new products for sleep apnea.
The company has yet released its earnings results for the second quarter. In the first quarter, the company reported a net profit of NT$56.73 million, or NT$0.68 per share, up 37 percent from NT$41.41 million, or NT$0.49 per share a year ago.
Wang said the company estimated that its litigation costs this year would be less than the NT$70 million posted last year.
Shares of Apex Medical dropped 2.24 percent to NT$56.7 yesterday, underperforming the benchmark TAIEX, which was up 0.43 percent.
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
Nvidia Corp’s GB300 platform is expected to account for 70 to 80 percent of global artificial intelligence (AI) server rack shipments this year, while adoption of its next-generation Vera Rubin 200 platform is to gradually gain momentum after the third quarter of the year, TrendForce Corp (集邦科技) said. Servers based on Nvidia’s GB300 chips entered mass production last quarter and they are expected to become the mainstay models for Taiwanese server manufacturers this year, Trendforce analyst Frank Kung (龔明德) said in an interview. This year is expected to be a breakout year for AI servers based on a variety of chips, as
Global semiconductor stocks advanced yesterday, as comments by Nvidia Corp chief executive officer Jensen Huang (黃仁勳) at Davos, Switzerland, helped reinforce investor enthusiasm for artificial intelligence (AI). Samsung Electronics Co gained as much as 5 percent to an all-time high, helping drive South Korea’s benchmark KOSPI above 5,000 for the first time. That came after the Philadelphia Semiconductor Index rose more than 3 percent to a fresh record on Wednesday, with a boost from Nvidia. The gains came amid broad risk-on trade after US President Donald Trump withdrew his threat of tariffs on some European nations over backing for Greenland. Huang further
HSBC Bank Taiwan Ltd (匯豐台灣商銀) and the Taiwan High Prosecutors Office recently signed a memorandum of understanding (MOU) to enhance cooperation on the suspicious transaction analysis mechanism. This landmark agreement makes HSBC the first foreign bank in Taiwan to establish such a partnership with the High Prosecutors Office, underscoring its commitment to active anti-fraud initiatives, financial inclusion, and the “Treating Customers Fairly” principle. Through this deep public-private collaboration, both parties aim to co-create a secure financial ecosystem via early warning detection and precise fraud prevention technologies. At the signing ceremony, HSBC Taiwan CEO and head of banking Adam Chen (陳志堅)